November 25, 2024 - 22:01

IceCure Medical Ltd. has announced that its next-generation multiprobe cryoablation technology has received a Notice of Allowance from Japan's Patent Office. This significant development marks a key milestone for the company's innovative approach to minimally invasive medical procedures.
The multiprobe cryoablation technology is designed to enhance the effectiveness and efficiency of cryoablation treatments, which are used to destroy abnormal tissues through extreme cold. This advancement is expected to provide physicians with improved tools for treating various medical conditions, potentially leading to better patient outcomes.
The approval from Japan's Patent Office underscores the technological advancements that IceCure is bringing to the field of cryoablation, positioning the company for growth in the competitive medical technology market.
January 21, 2026 - 07:13
Midday Update: Materials Sector Rises While Information Technology Faces ChallengesIn a notable shift on the Australian Securities Exchange (ASX) at midday Wednesday, the materials sector experienced a significant boost, climbing over 2%. This surge in materials stocks stands out...
January 20, 2026 - 22:16
Houston VA Transforms Veteran Care with Advanced Heart TechnologyThe Houston Veterans Affairs Medical Center has introduced the groundbreaking OmniaSecure defibrillation lead device, marking a significant advancement in cardiac care for veterans. This innovative...
January 20, 2026 - 05:17
Transforming Hospitality: Insights from Johan Ohlin, CTO of IRIS Software SystemsAs the hospitality industry adapts to the changing landscape of digital engagement, mobile ordering, and ancillary revenue, few technology providers have witnessed this transformation as closely as...
January 19, 2026 - 01:40
Examining the Implications of Musk's xAI on Acceptable AI PracticesRecent developments surrounding xAI, the artificial intelligence venture founded by Elon Musk, have sparked significant debate about the ethical boundaries of AI technology. As the company pushes...